Literature DB >> 33819458

Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengers.

Fabrizio Gardoni1, Monica Di Luca2.   

Abstract

N-methyl-d-aspartate receptors (NMDARs) are glutamate-gated ion channels that support essential functions throughout the brain. NMDARs are tetramers composed of the GluN1 subunit in complex with GluN2- and GluN3-type regulatory subunits, resulting in the formation of various receptor subtypes throughout the central nervous system (CNS), characterised by different kinetics, biophysical and pharmacological properties, and the abilities to interact with specific partners at dendritic spines. NMDARs are expressed at high levels, are widely distributed throughout the brain, and are involved in several physiological and pathological conditions. Here, we will focus on the GluN2A- and GluN2B-containing NMDARs found at excitatory synapses and their interactions with plasticity-relevant proteins, such as the postsynaptic density family of membrane-associated guanylate kinases (PSD-MAGUKs), Ca2+/calmodulin-dependent kinase II (CaMKII) and synaptonuclear protein messengers. The dynamic interactions between NMDAR subunits and various proteins regulating synaptic receptor retention and synaptonuclear signalling mediated by protein messengers suggest that the NMDAR serves as a key molecular player that coordinates synaptic activity and cell-wide events that require gene transcription. Importantly, protein-protein interactions at the NMDAR complex can also contribute to synaptic dysfunction in several brain disorders. Therefore, the modulation of the molecular composition of the NMDAR complex might represent a novel pharmacological approach for the treatment of certain disease states.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Brain disorders; Dendritic spines; Scaffolding proteins; Synaptonuclear messengers; Trafficking

Mesh:

Substances:

Year:  2021        PMID: 33819458     DOI: 10.1016/j.neuropharm.2021.108551

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  3 in total

1.  Clonidine ameliorates cerebral ischemia-reperfusion injury by up-regulating the GluN3 subunits of NMDA receptor.

Authors:  Jing Chen; Juan Zhang; Dan-Dan Yang; Zi-Cheng Li; Bo Zhao; Yue Chen; Zhi He
Journal:  Metab Brain Dis       Date:  2022-06-21       Impact factor: 3.655

2.  Nanoscale regulation of Ca2+ dependent phase transitions and real-time dynamics of SAP97/hDLG.

Authors:  Premchand Rajeev; Nivedita Singh; Adel Kechkar; Corey Butler; Narendrakumar Ramanan; Jean-Baptiste Sibarita; Mini Jose; Deepak Nair
Journal:  Nat Commun       Date:  2022-07-22       Impact factor: 17.694

Review 3.  Role of N-Methyl-D-Aspartate Receptor NR2B Subunit in Inflammatory Arthritis-Induced Chronic Pain and Peripheral Sensitized Neuropathic Pain: A Systematic Review.

Authors:  Yu Meng; Hai Li Shen
Journal:  J Pain Res       Date:  2022-07-18       Impact factor: 2.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.